Immunotoxin Therapy in Treating Patients With Advanced Cancer

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
5469
Conditions: Cervical Cancer|Fallopian Tube Cancer|Head and Neck Cancer|Lung Cancer|Malignant Mesothelioma|Ovarian Cancer|Pancreatic Cancer|Peritoneal Cavity Cancer
Start Date: December 1, 2000
Phase: Phase I
Status: Completed
NCT ID: NCT00006981
Study Type: Interventional
Intervention: Biological: SS1(dsFv)-PE38 immunotoxin
Study Design: Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: National Cancer Institute (NCI)
Ages: Adult|Senior
Enrollment: 0
Funded By: NIH
First Received: December 6, 2000
End Date:
Last Updated: January 9, 2010
Last Verified: May 1, 2005